Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy (Q62089583)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

5 references

12 September 2020

5 November 2020

7 April 2021

24 August 2022

10 October 2022

Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

0 references

9 references

24 March 2019

25 April 2019

17 June 2019

19 June 2019

9 September 2019

7 November 2019

20 November 2019

12 September 2020

5 November 2020

1 reference

9 September 2019

1 reference

7 November 2019

1 reference

20 November 2019

1 reference

12 September 2020

angiogenesis inhibitor

1 reference

5 November 2020

1 reference

7 April 2021

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Mihaela Popescu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Cătălina Bogdan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Dumitriţa Rugină

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Corina Ionescu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

language of work or name

English

0 references

publication date

3 July 2018

13 references

24 March 2019

25 April 2019

17 June 2019

19 June 2019

9 September 2019

7 November 2019

20 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

12 September 2020

5 November 2020

7 April 2021

24 August 2022

10 October 2022

Drug Design, Development and Therapy

13 references

24 March 2019

25 April 2019

17 June 2019

19 June 2019

9 September 2019

7 November 2019

20 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

12 September 2020

5 November 2020

7 April 2021

24 August 2022

10 October 2022

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

1985-1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial

12 April 2020

copyright license

12 references

24 March 2019

25 April 2019

17 June 2019

19 June 2019

9 September 2019

7 November 2019

20 November 2019

12 September 2020

5 November 2020

7 April 2021

24 August 2022

10 October 2022

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7

1 reference

12 December 2020

Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia

1 reference

12 December 2020

Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure

1 reference

12 December 2020

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

12 December 2020

Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression

1 reference

12 December 2020

Advanced glycation: an important pathological event in diabetic and age related ocular disease

1 reference

12 December 2020

Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues

1 reference

12 December 2020

Biochemistry and molecular cell biology of diabetic complications

1 reference

12 December 2020

The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

1 reference

12 December 2020

Polyol pathway and protein kinase C activity of rat Schwannoma cells

1 reference

12 December 2020

Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells

1 reference

12 December 2020

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

1 reference

12 December 2020

Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution.

1 reference

12 December 2020

Endogenous inhibitors of angiogenesis.

1 reference

12 December 2020

The retinal pigment epithelium in visual function

1 reference

12 December 2020

Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia

1 reference

12 December 2020

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner

1 reference

12 December 2020

Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression

1 reference

12 December 2020

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

1 reference

12 December 2020

Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats

1 reference

12 December 2020

Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat.

1 reference

12 December 2020

The role of protein kinase C activation and the vascular complications of diabetes

1 reference

12 December 2020

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

1 reference

12 December 2020

Thrombospondins in cancer

1 reference

12 December 2020

Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration

1 reference

12 December 2020

Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications

1 reference

12 December 2020

Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes

1 reference

12 December 2020

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

1 reference

12 December 2020

Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).

1 reference

12 December 2020

Mediators of ocular angiogenesis

1 reference

12 December 2020

PKC and the control of localized signal dynamics.

1 reference

12 December 2020

The cellular expression of antiangiogenic factors in fetal primate macula

1 reference

12 December 2020

Activation of protein kinase C isoforms and its impact on diabetic complications

1 reference

12 December 2020

1 reference

12 December 2020

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes

1 reference

12 December 2020

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

1 reference

12 December 2020

AGEs and diabetic retinopathy.

1 reference

12 December 2020

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

1 reference

12 December 2020

Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy

1 reference

12 December 2020

Oxidative stress and diabetic complications

1 reference

12 December 2020

Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice

1 reference

12 December 2020

Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes

1 reference

12 December 2020

Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species

1 reference

12 December 2020

Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

1 reference

12 December 2020

The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells

1 reference

12 December 2020

Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol

1 reference

12 December 2020

Evaluation of the Stability and Antioxidant Activity of Nanoencapsulated Resveratrol during in Vitro Digestion

1 reference

12 December 2020

Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation

1 reference

12 December 2020

Global prevalence and major risk factors of diabetic retinopathy

1 reference

12 December 2020

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

1 reference

12 December 2020

Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

1 reference

12 December 2020

Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: its possible relevance to clinical diabetic retinopathy

1 reference

12 December 2020

Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium.

1 reference

12 December 2020

Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization.

1 reference

12 December 2020

PKC activation by resveratrol derivatives with unsaturated aliphatic chain

1 reference

12 December 2020

Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability

1 reference

12 December 2020

Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway

1 reference

12 December 2020

Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways

1 reference

12 December 2020

Advances in our understanding of diabetic retinopathy.

1 reference

12 December 2020

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment

1 reference

12 December 2020

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.

1 reference

12 December 2020

Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study

1 reference

12 December 2020

Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems

1 reference

12 December 2020

Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy

1 reference

12 December 2020

Resveratrol-loaded polymeric nanoparticles: validation of an HPLC-PDA method to determine the drug entrapment and evaluation of its antioxidant activity.

1 reference

12 December 2020

Advanced glycation end products and diabetic retinopathy

1 reference

12 December 2020

Vascular endothelial growth factor signaling in hypoxia and inflammation

1 reference

12 December 2020

Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential

1 reference

12 December 2020

Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration

1 reference

12 December 2020

Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.

1 reference

12 December 2020

Molecular mechanisms of diabetic vascular complications

1 reference

12 December 2020

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy

1 reference

12 December 2020

Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types

1 reference

12 December 2020

Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets

1 reference

12 December 2020

Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS.

1 reference

12 December 2020

The catalytic subunit of DNA-dependent protein kinase is required for cellular resistance to oxidative stress independent of DNA double-strand break repair.

1 reference

12 December 2020

Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo

1 reference

12 December 2020

Mechanisms regulating endothelial permeability

1 reference

12 December 2020

Recombinant pigment epithelium-derived factor PEDF binds vascular endothelial growth factor receptors 1 and 2.

1 reference

12 December 2020

Fluorescence quenching study of resveratrol binding to zein and gliadin: Towards a more rational approach to resveratrol encapsulation using water-insoluble proteins

1 reference

12 December 2020

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema

1 reference

12 December 2020

Diabetes mellitus: The epidemic of the century

1 reference

12 December 2020

Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection

1 reference

12 December 2020

SIRT1 mediated inhibition of VEGF/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization

1 reference

12 December 2020

Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach.

1 reference

12 December 2020

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

1 reference

12 December 2020

Resveratrol-loaded Nanoparticles Induce Antioxidant Activity against Oxidative Stress

1 reference

12 December 2020

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol

1 reference

12 December 2020

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

1 reference

12 December 2020

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy

1 reference

12 December 2020

Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway

1 reference

12 December 2020

Increased intestinal permeation and modulation of presystemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems

1 reference

12 December 2020

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).

1 reference

12 December 2020

Retinal pigment epithelium-secretome: A diabetic retinopathy perspective.

1 reference

12 December 2020

A Review of Ranibizumab for the Treatment of Diabetic Retinopathy

1 reference

12 December 2020

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema.

1 reference

12 December 2020

Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.

1 reference

12 December 2020

Anti-Vascular Endothelial Growth Factor Injections: The New Standard of Care in Proliferative Diabetic Retinopathy?

1 reference

12 December 2020

Ultrasound processed nanoemulsion: A comparative approach between resveratrol and resveratrol cyclodextrin inclusion complex to study its binding interactions, antioxidant activity and UV light stability.

1 reference

12 December 2020

Potential role of sirtuin 1 in Müller glial cells in mice choroidal neovascularization.

1 reference

12 December 2020

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant.

1 reference

12 December 2020

Resveratrol for the Management of Diabetes and its Downstream Pathologies

1 reference

12 December 2020

Identifiers

DOI

10.2147/DDDT.S156941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30013318%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference